The influence of personality factors on disease progression and health‐related quality of life in people with ALS

References

• O'Boyle C., Waldron D. Quality of life issues in palliative medicine. J Neurol 1997; 244: S18–25
   PubMed Web of Science ®Google Scholar
• Hardiman O., Hickey A., O'Donerty L. Physical decline and quality of life in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5: 230–4
   PubMed Web of Science ®Google Scholar
• Neudert C., Wasner M., Borasio G. D. Individual quality of life is not correlated with health‐related quality of life or physical function in patients with amyotrophic lateral sclerosis. J Palliat Med 2004; 7: 551–7
   PubMedGoogle Scholar
• Nelson N., Trail M., Van J., Appel S., Lai E. Quality of life in patients with amyotrophic lateral sclerosis: perceptions, coping resources, and illness characteristics. J Palliat Med 2003; 6: 417–24
   PubMedGoogle Scholar
• Borasio G., Voltz R., Miller R. Palliative care in amyotrophic lateral sclerosis. Neurol Clin 2001; 19: 829–47
   PubMed Web of Science ®Google Scholar
• Bremer B., Simone A., Walsh S., Simmons Z., Felgoise S. Factors supporting quality of life over time for individuals with amyotrophic lateral sclerosis: the role of positive self‐perception and religiosity. Ann Behav Med 2004; 28: 119–25
   PubMed Web of Science ®Google Scholar
• Nygren I., Askmark H. Self‐reported quality of life in amyotrophic lateral sclerosis. J Palliat Med 2006; 9: 304–8
   PubMed Web of Science ®Google Scholar
• Bourke S., Tomlinson M., Williams T., Bullock R., Shaw P., Gibson G. Effects of non‐invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomized controlled trial. Lancet Neurol 2006; 5: 140–7
   PubMed Web of Science ®Google Scholar
• Damiano A., Patrick D., Guzman G., Gawel M., Gelinas D., Natter H., et al. Measurement of health‐related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies. Med Care 1999; 37: 15–26
   PubMed Web of Science ®Google Scholar
• Olney R., Lomen‐Hoerth C. Exit strategies in ALS: an influence of depression or despair?. Neurology 2005; 65: 9–10
   PubMed Web of Science ®Google Scholar
• Lou J‐S., Reeves A., Benice T., Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology 2003; 60: 122–1223
   PubMed Web of Science ®Google Scholar
• Rabkin J., Albert S., Del Bene M., O'Sullivan I., Tider T., Rowland L., et al. Prevalence of depressive disorders and change over time in late‐stage ALS. Neurology 2005; 65: 62–7
   PubMed Web of Science ®Google Scholar
• Lomen‐Hoerth C., Murphy J., Langmore S., Kramer J. H., Olney R. K., Miller B. Are amyotrophic lateral sclerosis patients cognitively normal?. Neurology 2003; 60: 1094–7
   PubMed Web of Science ®Google Scholar
• Schreiber H., Gaigalat T., Wiedemuth‐Catrinescu U., Graf M., Uttner I., Muche R., et al. Cognitive function in bulbar‐ and spinal‐onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients. J Neurol 2005; 252: 772–81
   PubMed Web of Science ®Google Scholar
• Murphy P., Albert S., Weber C., Del Bene M., Rowland L. Impact of spirituality and religiousness on outcomes in patients with ALS. Neurology 2000; 55: 1581–4
   PubMed Web of Science ®Google Scholar
• McDonald E., Wiedenfeld S., Hillel A., Carpenter C., Walter R. Survival in amyotrophic lateral sclerosis. Arch Neurol 1994; 51: 17–23
   PubMed Web of Science ®Google Scholar
• Hecht M., Hillemacher T., Grasel E., Tigges S., Winterholler M., Heuss D., et al. Subjective experience and coping in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2002; 3: 225–31
   PubMed Web of Science ®Google Scholar
• Fegg M. J., Wasner M., Neudert C., Borasio G. D. Personal values and individual quality of life in palliative care patients. J Pain Symptom Manage 2005; 30: 154–9
   PubMed Web of Science ®Google Scholar
• McCrae R., John O. An introduction to the five‐factor model and its application. J Pers 1992; 60: 175–215
   PubMed Web of Science ®Google Scholar
• Weishaupt J., Bartels C., Poelking E., Dietrich J., Rohde G., Poeggeler B., et al. Reduced oxidative damage in ALS by high‐dose enteral melatonin treatment. J Pineal Res 2006; 41: 313–23
   PubMed Web of Science ®Google Scholar
• Beck A., Ward C., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–71
   PubMed Web of Science ®Google Scholar
• Costa P., McCrae R. Revised NEO Personality Inventory (NEO PI‐R) and NEO Five Factor Inventory. Professional Manual. Psychological Assessment Resources, Odessa, Fl 1992
   Google Scholar
• The ALSCNTF TreatmentStudy (ACTS) PhaseI‐II Study Group. The amyotrophic lateral sclerosis functional rating scale. Arch Neurol 1996; 53: 141–7
   PubMedGoogle Scholar
• Beck A. T., Steer R. A., Garbin M. G. Psychometric properties of the Beck Depression Inventory: 25 years of evaluation. Clin Psychol Rev 1988; 8: 77–100
   Web of Science ®Google Scholar
• Todd A., Russell D. Missing data: a review of current methods and applications in epidemiological research. Curr Opin Psychiatry 2004; 17: 315–21
   Google Scholar
• Lee‐Baggley D., Preece M., De Longis A. Coping with interpersonal stress: role of big five traits. J Pers 2005; 73: 1140–80
   Google Scholar
• Grossman A., Levin B., Bradley W. Premorbid personality characteristics of patients with ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2006; 7: 27–31
   PubMed Web of Science ®Google Scholar